JP2019504070A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019504070A5 JP2019504070A5 JP2018536455A JP2018536455A JP2019504070A5 JP 2019504070 A5 JP2019504070 A5 JP 2019504070A5 JP 2018536455 A JP2018536455 A JP 2018536455A JP 2018536455 A JP2018536455 A JP 2018536455A JP 2019504070 A5 JP2019504070 A5 JP 2019504070A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- injectable
- nacl
- compound
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009472 formulation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR16/70004 | 2016-01-14 | ||
| FR1670004A FR3046793B1 (fr) | 2016-01-14 | 2016-01-14 | Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2017/050075 WO2017121969A1 (fr) | 2016-01-14 | 2017-01-13 | Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019504070A JP2019504070A (ja) | 2019-02-14 |
| JP2019504070A5 true JP2019504070A5 (enExample) | 2019-11-28 |
Family
ID=55752640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018536455A Pending JP2019504070A (ja) | 2016-01-14 | 2017-01-13 | 新規ホスフィナン及びアザホスフィナン誘導体、それらを調製するための方法、並びにそれらを含有する医薬組成物 |
Country Status (47)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3046793B1 (fr) * | 2016-01-14 | 2018-01-05 | Les Laboratoires Servier | Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03001425A (es) * | 2000-08-17 | 2003-06-06 | Pfizer | Compuestos farmaceuticos. |
| SE0103272D0 (sv) * | 2001-09-28 | 2001-09-28 | Astrazeneca Ab | Chemical compounds |
| AU2002249275A1 (en) * | 2002-03-08 | 2003-09-22 | Warner-Lambert Company Llc | Oxo azabicyclic compounds |
| US7420000B2 (en) * | 2003-09-10 | 2008-09-02 | University Of Southern California | Amino phosphonate and amino bis-phosphonate derivatives |
| US20050143349A1 (en) * | 2003-12-17 | 2005-06-30 | Quatrx Pharmaceuticals Co. | Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels |
| EP1874322A1 (en) * | 2005-04-18 | 2008-01-09 | Bayer Schering Pharma Aktiengesellschaft | Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci |
| US8367706B2 (en) * | 2007-06-20 | 2013-02-05 | Merck Sharp & Dohme Corp. | Inhibitors of janus kinases |
| FR2920773B1 (fr) * | 2007-09-11 | 2009-10-23 | Servier Lab | Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2947266B1 (fr) * | 2009-06-26 | 2011-06-17 | Servier Lab | Nouveaux derives d'acide 2-mercaptocyclopentanecarboxylique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| BR112012005438A2 (pt) * | 2009-09-09 | 2018-03-20 | Gilead Sciences Inc | inibidores de vírus flaviviridae |
| MX2015000830A (es) * | 2012-07-18 | 2015-10-26 | Sunshine Lake Pharma Co Ltd | Derivados heterociclicos nitrogenosos y su aplicacion en farmacos. |
| FR3046793B1 (fr) * | 2016-01-14 | 2018-01-05 | Les Laboratoires Servier | Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2016
- 2016-01-14 FR FR1670004A patent/FR3046793B1/fr not_active Expired - Fee Related
- 2016-12-27 JO JOP/2016/0275A patent/JO3660B1/ar active
-
2017
- 2017-01-11 UY UY0001037072A patent/UY37072A/es unknown
- 2017-01-12 TW TW106100930A patent/TWI625334B/zh not_active IP Right Cessation
- 2017-01-12 AR ARP170100074A patent/AR107433A1/es unknown
- 2017-01-13 PT PT17706525T patent/PT3271368T/pt unknown
- 2017-01-13 UA UAA201808634A patent/UA121275C2/uk unknown
- 2017-01-13 JP JP2018536455A patent/JP2019504070A/ja active Pending
- 2017-01-13 MD MDE20180097T patent/MD3271368T2/ro not_active IP Right Cessation
- 2017-01-13 CU CUP2018000072A patent/CU20180072A7/es unknown
- 2017-01-13 EA EA201891599A patent/EA035072B1/ru not_active IP Right Cessation
- 2017-01-13 RU RU2018129027A patent/RU2729641C2/ru not_active IP Right Cessation
- 2017-01-13 MX MX2018008639A patent/MX367319B/es active IP Right Grant
- 2017-01-13 GE GEAP201714853A patent/GEP20207092B/en unknown
- 2017-01-13 CN CN201780008078.XA patent/CN108495857A/zh active Pending
- 2017-01-13 CA CA3011184A patent/CA3011184C/fr not_active Expired - Fee Related
- 2017-01-13 HK HK18103808.6A patent/HK1244283B/zh not_active IP Right Cessation
- 2017-01-13 PL PL17706525T patent/PL3271368T3/pl unknown
- 2017-01-13 ME MEP-2019-23A patent/ME03305B/me unknown
- 2017-01-13 HR HRP20190193TT patent/HRP20190193T1/hr unknown
- 2017-01-13 DK DK17706525.7T patent/DK3271368T3/da active
- 2017-01-13 BR BR112018014020-1A patent/BR112018014020A2/pt not_active IP Right Cessation
- 2017-01-13 SG SG11201805757WA patent/SG11201805757WA/en unknown
- 2017-01-13 HU HUE17706525A patent/HUE042924T2/hu unknown
- 2017-01-13 US US15/548,533 patent/US10138260B2/en not_active Expired - Fee Related
- 2017-01-13 SI SI201730013T patent/SI3271368T1/sl unknown
- 2017-01-13 TR TR2018/20430T patent/TR201820430T4/tr unknown
- 2017-01-13 WO PCT/FR2017/050075 patent/WO2017121969A1/fr not_active Ceased
- 2017-01-13 EP EP17706525.7A patent/EP3271368B1/fr active Active
- 2017-01-13 LT LTEP17706525.7T patent/LT3271368T/lt unknown
- 2017-01-13 KR KR1020187023228A patent/KR20180101522A/ko not_active Abandoned
- 2017-01-13 AU AU2017207003A patent/AU2017207003B2/en not_active Expired - Fee Related
- 2017-01-13 RS RS20190105A patent/RS58338B1/sr unknown
- 2017-01-13 MA MA41798A patent/MA41798B1/fr unknown
- 2017-01-13 PE PE2018001210A patent/PE20181503A1/es unknown
- 2017-01-13 ES ES17706525T patent/ES2709376T3/es active Active
- 2017-01-13 TN TNP/2018/000226A patent/TN2018000226A1/fr unknown
-
2018
- 2018-06-26 PH PH12018501373A patent/PH12018501373A1/en unknown
- 2018-06-29 ZA ZA2018/04391A patent/ZA201804391B/en unknown
- 2018-07-04 IL IL260425A patent/IL260425B/en active IP Right Grant
- 2018-07-05 SV SV2018005721A patent/SV2018005721A/es unknown
- 2018-07-06 NI NI201800073A patent/NI201800073A/es unknown
- 2018-07-09 DO DO2018000165A patent/DOP2018000165A/es unknown
- 2018-07-09 CL CL2018001862A patent/CL2018001862A1/es unknown
- 2018-07-11 EC ECSENADI201851972A patent/ECSP18051972A/es unknown
- 2018-07-12 CO CONC2018/0007271A patent/CO2018007271A2/es unknown
- 2018-10-04 US US16/151,597 patent/US10654878B2/en not_active Expired - Fee Related
- 2018-12-10 CY CY20181101320T patent/CY1121154T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015078230A5 (enExample) | ||
| CL2019003669A1 (es) | Inhibidores de quinasa alk2 que contienen imidazol. | |
| MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
| MX385984B (es) | Inhibidores de isoindolinona de la interacción mdm2-p53 que tienen actividad antineoplásica. | |
| ZA202006377B (en) | Boronic acid derivatives and therapeutic uses thereof | |
| EA201892734A1 (ru) | ПРОИЗВОДНЫЕ АЗАБЕНЗИМИДАЗОЛА В КАЧЕСТВЕ ИНГИБИТОРОВ pI3K BETA | |
| AR107864A1 (es) | ÁCIDO 7a,11b-DIHIDROXI-6a-ETIL-5b-COLAN-24-OICO Y COMPOSICIONES FARMACÉUTICAS | |
| MX379900B (es) | Inhibidores de isoindolinona de la interaccion mdm2-p53 que tienen actividad antineoplasica. | |
| MX373040B (es) | Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservador. | |
| MX374628B (es) | Formulacion que comprende un agente hipolipidemico. | |
| EA201890534A1 (ru) | Новые аннелированные феноксиацетамиды | |
| MX2017012295A (es) | Derivados formilados n-heterociclicos como inhibidores de fgfr4. | |
| DOP2016000254A (es) | Formulaciones farmeceuticas de inhibidor de la quinasa pan-raf, procedimientos para su preparacion, y metodos de uso. | |
| EA201890532A1 (ru) | Новые аннелированные бензамиды | |
| MX383577B (es) | Derivados sustituidos de guanidina. | |
| EA201890906A1 (ru) | ПРОИЗВОДНЫЕ ХИНОКСАЛИНА И ПИРИДОПИРАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ | |
| PH12015501945B1 (en) | Formulations of organic compounds | |
| MX2017015812A (es) | Formulaciones farmaceuticas inyectables de lefamulina. | |
| MY182634A (en) | Pharmaceutical containing sodium-dependent phosphate transporter inhibitor | |
| JOP20170197A1 (ar) | الصيغة الجديدة التي تشتمل على مشتق بنزيميدازول | |
| JP2019504070A5 (enExample) | ||
| BR112017024126B8 (pt) | Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos | |
| HRP20201598T1 (hr) | Pripravci | |
| MX2019006939A (es) | Preparacion liquida parenteral que comprende compuesto de carbamato. | |
| EA201890477A1 (ru) | Инкапсулированная композиция финголимода |